12,000% Return in 5 Years: This Multibagger Personal Care Company Stock Hits Record High After Strong Q1 Results
Join Us
Follow Us
Over the past year, the stock has surged 760 per cent. Its three-year return stands at 8,691 per cent, while the five-year return is around 12,000 per cent.
✨ Key Takeaways
Cupid Ltd shares hit a fresh record high of Rs 295 on August 13, gaining 1.72 per cent, after the company reported a sharp improvement in its June quarter results. The stock has delivered exceptional returns over the past five years, supported by strong earnings growth, higher revenue and improving operating performance.
Cupid reported consolidated net profit of Rs 44.1 crore in Q1FY27, nearly three times the Rs 15 crore recorded in the corresponding quarter last year. Revenue from operations surged 159 per cent year-on-year (YoY) to Rs 154.7 crore from Rs 59.8 crore.
Operating performance also improved significantly. EBITDA rose to Rs 60.1 crore from Rs 16.5 crore, while the EBITDA margin expanded to 38.8 per cent from 27.5 per cent. On a standalone basis, net sales increased 158.7 per cent YoY to Rs 154.72 crore, while net profit jumped 194.07 per cent to Rs 44.16 crore from Rs 15.02 crore.
Standalone EBITDA increased 191.04 per cent to Rs 62.34 crore from Rs 21.42 crore. Profit before Tax rose to Rs 59.93 crore from Rs 19.56 crore. Interest expenses increased to Rs 1.11 crore from Rs 0.62 crore, while tax expenses rose to Rs 15.77 crore from Rs 4.54 crore.
The strong Q1 performance was supported by higher revenue, improved profitability and stronger margins. Cupid said it implemented a minimum 10 per cent price increase across its export portfolio, which helped improve realisations and margins. A favourable USD/INR exchange-rate environment also supported export realisations.
The company has raised its FY27 guidance to revenue of Rs 725-750 crore and net profit of Rs 210-225 crore. Cupid expects growth to be supported by a strong Order Book, international B2B demand and expansion in its consumer healthcare and FMCG businesses.
The company also expects sizable orders for its IVD Kits portfolio from multiple state governments. International opportunities have increased following CE certifications, with several potential orders reportedly in the final stages of the award process.
Cupid shares have gained 40 per cent in the past month, 133 per cent in three months and 240 per cent in six months. Over the past year, the stock has surged 760 per cent. Its three-year return stands at 8,691 per cent, while the five-year return is around 12,000 per cent.
The stock gained around 12 per cent over two trading sessions to touch Rs 295 on August 13. It was trading at around Rs 288.50 at 10:45 AM, down 0.47 per cent, suggesting some Intraday profit-taking after the recent rally and strong Q1 results.
Going ahead, Cupid's management remains focused on maintaining healthy margins, disciplined execution, manufacturing expansion and product innovation. The company is also targeting growth in international B2B healthcare, consumer healthcare and FMCG. Its order pipeline and expanding product portfolio are expected to support performance in the second half of FY27.
However, the sharp rise in the stock price has significantly raised market expectations. Sustaining the current earnings growth and delivering the upgraded FY27 guidance will therefore remain key factors for Cupid shares going forward.
Disclaimer: The article is for informational purposes only and not investment advice.